Diligence memo · auto-generated · as of July 2, 2026
Vestagen Protective Technologies, Inc.
Vestagen Protective Technologies, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Vestagen Protective Technologies, Inc. operates in Biotechnology, based in ORLANDO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Vestagen Protective Technologies, Inc. has raised $26M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $16M on 2017-03-31.
Most recent recorded round closed around 2017-03-31.
Valuation (modeled)modeled
Provath models Vestagen Protective Technologies, Inc. at approximately $635M (range $32M–$2.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.80× the median modeled value of Series B Biotechnology companies in 2016–2018 (101 peers) — value vs value, same stage and era. Within the normal band (80% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 15 months.
Last raise 9.3 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 32.0× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 72% of Biotechnology peers (4293 compared).
Modeled value ranks above 85% of those peers.
Closest niche peers: Liquid BioScience, Inc., Amphivena Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Tetra Discovery Partners, Inc., ECM Therapeutics, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.